SCHEMBL7051654

SCHEMBL7051654

O=C1Nc2cc(Cl)c(Cl)c(Cl)c2C(=O)C1=NOC(=O)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.39
HPGD P15428 4/20 0.39
ALDH1A1 P00352 3/20 0.39
F2 P00734 2/20 0.39
ATM Q13315 1/20 0.39
MEN1 O00255 2/20 0.38
MAPK1 P28482 1/20 0.38
CYP2C9 P11712 1/20 0.38
GAA P10253 2/20 0.38
TGM2 P21980 1/20 0.36
MAPT P10636 3/20 0.35
CES1 P23141 1/20 0.34
LMNA P02545 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33
HSP90AA1 P07900 1/20 0.33
GFER P55789 1/20 0.33
HCRTR1 O43613 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7051545 0.91 KMT2A (0.39) KMT2AHPGDALDH1A1F2ATM
SCHEMBL7051548 0.87 CES1 (0.48) KMT2AHPGDALDH1A1F2ATM
SCHEMBL7054980 0.86 MAPT (0.38) KMT2AHPGDALDH1A1F2ATM
SCHEMBL7049385 0.86 MAPT (0.38) KMT2AHPGDALDH1A1F2ATM
SCHEMBL7051552 0.83 CES1 (0.47) KMT2AHPGDALDH1A1F2ATM
SCHEMBL7048302 0.82 CES1 (0.36) TGM2CES1
SCHEMBL7054322 0.81 HPGD (0.37) KMT2AHPGDALDH1A1F2ATM
SCHEMBL7052934 0.81 KMT2A (0.41) KMT2AHPGDALDH1A1F2ATM
SCHEMBL7051535 0.80 CES1 (0.48) KMT2AHPGDALDH1A1F2ATM
SCHEMBL7051070 0.80 MAPT (0.38) KMT2AHPGDALDH1A1F2ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0706396-B1 1,2,3,4-TETRAHYDROQUINOLINE-2,3,4-TRIONE-3 OR 4-OXIMES AND USE OREGON STATE (US) 2003-05-02 EP disclosed
EP-0706396-A4 1,2,3,4-TETRAHYDROQUINOLINE-2,3,4-TRIONE-3 OR 4-OXIMES AND USE OREGON STATE (US) 1998-12-09 EP disclosed
US-5652368-A NERVOUS SYSTEM DISORDERS, ALZHEIMER'S DISEASE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1997-07-29 US disclosed
EP-0706396-A1 1,2,3,4-TETRAHYDROQUINOLINE-2,3,4-TRIONE-3 OR 4-OXIMES AND USE STATE OF OREGON ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION ON BEHALF OF OREGON STATE UNIVERSITY (US) 1996-04-17 EP disclosed
US-5475007-A Preventing convulsions THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1995-12-12 US disclosed
WO-1994027605-A1 1,2,3,4-TETRAHYDROQUINOLINE-2,3,4-TRIONE-3 OR 4-OXIMES AND USE STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON, EUGENE, OREGON (US) 1994-12-08 WO disclosed